The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design
Open accessAbstract
The inappropriate use of antibiotics and an inadequate control of infections have led to the emergence of resistant strains which represent a major threat to public health and the global economy. Therefore, research and development of a new generation of antimicrobials to mitigate the spread of antibiotic resistance has become imperative. Current research and technology developments have promoted the improvement of antimicrobial agents that can selectively interact with a target site (e.g., a gene or a cellular process) or a specific pathogen. Antimicrobial peptides and metal nanoparticles exemplify a novel approach to treat infectious diseases. Nonetheless, combinatorial treatments have been recently considered as an excellent platform to design and develop the next generation of antibacterial agents. The combination of different drugs offers many advantages over their use as individual chemical moieties; these include a reduction in dosage of the individual drugs, fewer side effects compared to the monotherapy, reduced risk for the development of drug resistance, a better combined response compared to the effect of the individual drugs (synergistic effects), wide-spectrum antibacterial action, and the ability to attack simultaneously multiple target sites, in many occasions leading to an increased antibacterial effect. The selection of the appropriate combinatorial treatment is critical for the successful treatment of infections. Therefore, the design of combinatorial treatments provides a pathway to develop antimicrobial therapeutics with broad-spectrum antibacterial action, bactericidal instead of bacteriostatic mechanisms of action, and better efficacy against multidrug-resistant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
The bactericidal effect of silver nanoparticles
Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T., & Yacaman, M. J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/10/059 · Cited by 6,668
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
A review of the biomaterials technologies for infection-resistant surfaces
Campoccia, D., Montanaro, L., & Arciola, C. R. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.089 · Cited by 1,358
Shahverdi, A. R., Fakhimi, A., Shahverdi, H. R., & Minaian, S. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.02.001 · Cited by 1,299
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
The antimicrobial peptides and their potential clinical applications.
Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019) · PubMed · Cited by 1,116
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Biogenic synthesis of nanoparticles: A review
Sharma, D., Kanchi, S., & Bisetty, K. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.11.002 · Cited by 948
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S., & Collins, J. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006276 · Cited by 756
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Cathelicidins: family of antimicrobial peptides. A review
Kościuczuk, E. M., Lisowski, P., Jarczak, J., Strzałkowska, N., Jóźwik, A., Horbańczuk, J., Krzyżewski, J., Zwierzchowski, L., & Bagnicka, E. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1997-x · Cited by 570
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555
Safety of Nanoparticles in Medicine
Wolfram, J., Zhu, M., Yang, Y., Shen, J., Gentile, E., Paolino, D., Fresta, M., Nie, G., Chen, C., Shen, H., et al. (2015) · Current Drug Targets · doi:10.2174/1389450115666140804124808 · Cited by 532
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01153 · Cited by 532
Shaikh, S., Nazam, N., Rizvi, S. M. D., Ahmad, K., Baig, M. H., Lee, E. J., & Choi, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102468 · Cited by 507
Drug/device combinations for local drug therapies and infection prophylaxis
Wu, P., & Grainger, D. W. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.031 · Cited by 491
Tiwari, V., Mishra, N., Gadani, K., Solanki, P. S., Shah, N. A., & Tiwari, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01218 · Cited by 448
Schillaci, O., Fontana, S., Monteleone, F., Taverna, S., Di Bella, M. A., Di Vizio, D., & Alessandro, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-05002-y · Cited by 424
Mycobacterium tuberculosis infection of host cells in space and time
Bussi, C., & Gutierrez, M. G. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz006 · Cited by 344
Chopade, B. A., Singh, R., Wagh, P., Wadhwani, S., Gaidhani, S., Kumbhar, A., & Bellare, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s48913 · Cited by 325
Vazquez-Muñoz, R., Meza-Villezcas, A., Fournier, P. G. J., Soria-Castro, E., Juarez-Moreno, K., Gallego-Hernández, A. L., Bogdanchikova, N., Vazquez-Duhalt, R., & Huerta-Saquero, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224904 · Cited by 307
Naqvi, S. Z., Kiran, U., Ali, Jamal, Hameed, Ahmed, & Ali (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s49284 · Cited by 299
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
Chung, P. Y., & Khanum, R. (2017) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2016.12.005 · Cited by 296
Antimicrobial peptides: new hope in the war against multidrug resistance
Mwangi, J., Hao, X., Lai, R., & Zhang, Z.-Y. (2019) · Zool. Res. · doi:10.24272/j.issn.2095-8137.2019.062 · Cited by 289
A practical demonstration of water disinfection using TiO2 films and sunlight
Gelover, S., Gómez, L. A., Reyes, K., & Teresa Leal, M. (2006) · Water Research · doi:10.1016/j.watres.2006.07.006 · Cited by 285
Zharkova, M. S., Orlov, D. S., Golubeva, O. Y., Chakchir, O. B., Eliseev, I. E., Grinchuk, T. M., & Shamova, O. V. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00128 · Cited by 272
The Concept of an Ideal Antibiotic: Implications for Drug Design
Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 271
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Aoki, W., & Ueda, M. (2013) · Pharmaceuticals · doi:10.3390/ph6081055 · Cited by 252
Duplantier, A. J., & van Hoek, M. L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00143 · Cited by 247
Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications
Boparai, J. K., & Sharma, P. K. (2019) · Protein & Peptide Letters · doi:10.2174/0929866526666190822165812 · Cited by 240
Antibiotic resistance: turning evolutionary principles into clinical reality
Andersson, D. I., Balaban, N. Q., Baquero, F., Courvalin, P., Glaser, P., Gophna, U., Kishony, R., Molin, S., & Tønjum, T. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa001 · Cited by 238
Discovery and development of new antibacterial drugs: learning from experience?
Jackson, N., Czaplewski, L., & Piddock, L. J. V. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky019 · Cited by 238
Synergistic Antibacterial Effects of Metallic Nanoparticle Combinations
Bankier, C., Matharu, R. K., Cheong, Y. K., Ren, G. G., Cloutman-Green, E., & Ciric, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-52473-2 · Cited by 225
Jesline, A., John, N. P., Narayanan, P. M., Vani, C., & Murugan, S. (2015) · Applied Nanoscience · doi:10.1007/s13204-014-0301-x · Cited by 222
The Antibacterial Activity of Ta-doped ZnO Nanoparticles
Guo, B.-L., Han, P., Guo, L.-C., Cao, Y.-Q., Li, A.-D., Kong, J.-Z., Zhai, H.-F., & Wu, D. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-1047-4 · Cited by 189
Kora, A. J., & Rastogi, L. (2013) · Bioinorganic Chemistry and Applications · doi:10.1155/2013/871097 · Cited by 155
Perturbation of physiological systems by nanoparticles
Zhang, Y., Bai, Y., Jia, J., Gao, N., Li, Y., Zhang, R., Jiang, G., & Yan, B. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60338e · Cited by 153
Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?
Divyashree, M., Mani, M. K., Reddy, D., Kumavath, R., Ghosh, P., Azevedo, V., & Barh, D. (2019) · Protein and Peptide Letters · doi:10.2174/0929866526666190925152957 · Cited by 148
Next-generation precision antimicrobials: towards personalized treatment of infectious diseases
de la Fuente‐Núñez, C., Torres, M. D. T., Mojica, F. J. M., & Lu, T. K. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.014 · Cited by 145
Recent advances in combinatorial drug screening and synergy scoring
Pemovska, T., Bigenzahn, J. W., & Superti‐Furga, G. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.008 · Cited by 122
Current concepts in combination antibiotic therapy for critically ill patients
Baronia, A. K., & Ahmed, A. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.132495 · Cited by 116
Synergistic Antimicrobial Effects of Silver/Transition-metal Combinatorial Treatments
Garza-Cervantes, J. A., Chávez‐Reyes, A., Castillo, E. C., García‐Rivas, G., Ortega-Rivera, O. A., Salinas, E., Ortiz‐Martínez, M., Gómez-Flores, S. L., Peña-Martínez, J. A., Pepi-Molina, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01017-7 · Cited by 112
Self-citationAntimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes
Starr, C. G., & Wimley, W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.09.008 · Cited by 108
Arya, S. S., Sharma, M. M., Das, R. K., Rookes, J. E., Cahill, D. M., & Lenka, S. K. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02021 · Cited by 108
Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs
Wang, G. (2013) · Pharmaceuticals · doi:10.3390/ph6060728 · Cited by 107
López-Carrizales, M., Velasco, K. I., Castillo, C. G., Flores, A., Magaña, M., Martínez-Castañón, G. A., & Martínez‐Gutiérrez, F. (2018) · Antibiotics · doi:10.3390/antibiotics7020050 · Cited by 107
Escárcega‐González, C. E., Garza-Cervantes, J. A., Rodríguez, A. V., & Morones‐Ramírez, J. R. (2018) · International Journal of Polymer Science · doi:10.1155/2018/7045852 · Cited by 106
Self-citationSi, Z., Lim, H. W., Tay, M. Y. F., Du, Y., Ruan, L., Qiu, H., Zamudio-Vázquez, R., Reghu, S., Chen, Y., Tiong, W. S., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201914304 · Cited by 102
Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection
Pirrone, V., Thakkar, N. J., Jacobson, J. M., Wigdahl, B. L., & Krebs, F. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00976-10 · Cited by 97
Degradation of naturally occurring and engineered antimicrobial peptides by proteases
Moncla, B. J., Pryke, K. M., Rohan, L. C., & Graebing, P. W. (2011) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2011.26059 · Cited by 95
Xu, L., Shao, C., Li, G., Shan, A., Chou, S., Wang, J., Ma, Q., & Dong, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-58014-6 · Cited by 87
Beyond conventional antibiotics — New directions for combination products to combat biofilm
Bayramov, D. F., & Neff, J. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.010 · Cited by 81
Gold Nanoparticles with Antibiotic‐Metallopolymers toward Broad‐Spectrum Antibacterial Effects
Yang, P., Pageni, P., Rahman, M. A., Bam, M., Zhu, T., Chen, Y. P., Nagarkatti, M., Decho, A. W., & Tang, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800854 · Cited by 77
Eckert, R., Brady, K. M., Greenberg, E. P., Qi, F., Yarbrough, D. K., He, J. G., McHardy, I. H., Anderson, M. H., & Shi, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-06 · Cited by 74
Ruden, S., Rieder, A., Ster, I. C., Schwartz, T., Mikut, R., & Hilpert, K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02740 · Cited by 70
Akbari, R., Hakemi-Vala, M., Fatemeh, P., Bevalian, P., Hashemi, A., & Bagheri, K. P. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0016 · Cited by 69
Koppen, B. C., Mulder, P. P. G., de Boer, L., Riool, M., Drijfhout, J. W., & Zaat, S. A. J. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.10.002 · Cited by 68
Synergistic antibacterial activity of gold nanoparticles caused by apoptosis‐like death
Lee, B., & Lee, D. G. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14357 · Cited by 68
Novel hollow titanium dioxide nanospheres with antimicrobial activity against resistant bacteria
de Dicastillo, C. L., Vidal, C. P., Galotto, M. J., Vásquez‐Martínez, Y., Torrent, C., Alburquenque, D., Pereira, A., & Escrig, J. (2019) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.10.167 · Cited by 63
Design and activity of a ‘dual-targeted’ antimicrobial peptide
He, J. G., Anderson, M. H., Shi, W., & Eckert, R. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.11.013 · Cited by 62
Marks, L. R., Clementi, E. A., & Håkansson, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063158 · Cited by 58
Garza-Cervantes, J. A., Mendiola-Garza, G., de Melo, E. M., Dugmore, T. I. J., Matharu, A. S., & Morones‐Ramírez, J. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-64127-9 · Cited by 56
Self-citationGarza-Cervantes, J. A., Escárcega‐González, C. E., Barriga‐Castro, E. D., Mendiola-Garza, G., Marichal‐Cancino, B. A., López-Vázquez, M. A., & Morones‐Ramírez, J. R. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s196470 · Cited by 55
Self-citationAre the physicochemical properties of antibacterial compounds really different from other drugs?
Ebejer, J.-P., Charlton, M. H., & Finn, P. W. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0143-5 · Cited by 54
Green synthesis of rifampicin-loaded copper nanoparticles with enhanced antimicrobial activity
Woźniak-Budych, M., Przysiecka, Ł., Langer, K., Peplińska, B., Jarek, M., Wiesner, M., Nowaczyk, G., & Jurga, S. (2017) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-017-5857-z · Cited by 54
Current advances in nanocarriers for biomedical research and their applications
Kerry, R. G., Shin, H., Gouda, S., Sahoo, S., Das, G., Fraceto, L. F., & Patra, J. K. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1478843 · Cited by 46
van der Weide, H., Jongh, D. M. C. V.-D., van der Meijden, A., Boers, S. A., Kreft, D., ten Kate, M. T., Falciani, C., Pini, A., Strandh, M., Bakker‐Woudenberg, I. A. J. M., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.05.019 · Cited by 46
Selvaraj, R. C. A., Mala, R., & Prasath, N. H. (2019) · Molecules · doi:10.3390/molecules24173055 · Cited by 44
Mao, R., Teng, D., Wang, X., Xi, D., Zhang, Y., Hu, X., Yang, Y., & Wang, J. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4508-z · Cited by 39
Montelongo-Peralta, L. Z., León‐Buitimea, A., Palma‐Nicolás, J. P., González‐Christen, J., & Morones‐Ramírez, J. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-42049-5 · Cited by 38
Self-citationGarza-Cervantes, J. A., Meza-Bustillos, J. F., Resendiz-Hernández, H., Suárez-Cantú, I. A., Ortega-Rivera, O. A., Salinas, E., Escárcega‐González, C. E., & Morones‐Ramírez, J. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00612 · Cited by 29
Self-citationRodríguez, A. V., Vasto-Anzaldo, X. G., León‐Buitimea, A., Zárate, X., & Morones‐Ramírez, J. R. (2020) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2020.2985101 · Cited by 27
Self-citationSelective activities of STAMPs against Streptococcus mutans
Huo, L., Huang, X., Ling, J., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5631 · Cited by 23
El-Sheekh, M. M., & El-Kassas, H. Y. (2014) · RENDICONTI LINCEI · doi:10.1007/s12210-014-0341-x · Cited by 22
Medhi, B., Sarma, P., Mahendiratta, S., & Prakash, A. (2018) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_218_18 · Cited by 21
Murugan, S. (2018) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2018v10i10.28069 · Cited by 18
Silver-containing nanoparticles in the research of new antimicrobial agents against ESKAPE pathogens
Borthagaray, G., Mondelli, M. A., Facchin, G., & Torre, M. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00008-0 · Cited by 12
Cited by
Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications
Talapko, J., Meštrović, T., Juzbašić, M., Tomas, M., Erić, S., Horvat Aleksijević, L., Bekić, S., Schwarz, D., Matić, S., Neuberg, M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101417 · Cited by 281
Self-Assembly Pathways and Antimicrobial Properties of Lysozyme in Different Aggregation States
Kummer, N., Wu, T., De France, K. J., Zuber, F., Ren, Q., Fischer, P., Campioni, S., & Nyström, G. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00870 · Cited by 46
Metadata
- Authors
- León-Buitimea, A., Garza-Cárdenas, C. R., Garza-Cervantes, J. A., Lerma-Escalera, J. A., & Morones-Ramírez, J. R.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-24
- Volume
- 11
- Pages
- 1669-1669
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3045445502
- Cited by
- 274
- References
- 84
- FWCI
- 23.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.